Searched for
API.MARKET
Virupaksha Organics files draft papers with Sebi for Rs 740 crore IPOPharmaceutical company Virupaksha Organics has filed preliminary papers with capital markets regulator Sebi to raise Rs 740 crore through a...- AI diet helping new-age companies run leanAI startups are betting on small teams, borrowing from the Silicon Valley playbook, to scale their operations and achieve significant reven...
- Pharma raw material makers in race to tank up on CXO talentSome of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...
- Concord Biotech IPO to open on August 4. Here are 10 things to know about the offerThe initial public offering (IPO) of Concord Biotech will open for subscription on August 4. The issue closes on August 8. The company's sh...
- Half a trillion-dollar FII inflows may be heading India’s way and focus is on 3 sectors: Saurabh Mukherjea“Given that western investors have $3.5 trillion invested in China, the sense I got from our meetings is that a substantial amount is going...
- Buy, sell or hold: What should you do with Supriya Lifescience after solid debut?“We like Supriya for its niche product portfolio, backward integrated business model and robust financials. It is well placed to tap the op...
- Glenmark Life IPO subscribed nearly 31 times on final dayMost analysts are positive on the company's future prospects and suggest subscribing to the issue. They believe the company, which is a spi...
- Glenmark Life Sciences IPO subscribed 4 times on Day 2Most analysts are positive on the company's future prospects and suggest subscribing to the issue. They believe the company, which is a spi...
- Glenmark Life Sciences IPO sails through on Day 1Most analysts are positive on the company's future prospects and suggest subscribing to the issue. They believe the company, which is a spi...
- Glenmark Life’s Rs 1,600-cr issue may open next weekThe initial public offering (IPO) comprises a fresh issue of Rs 1,160 crore and sale of 7.3 million shares by listed promoter Glenmark Phar...
- Piramal Pharma completes acquisition of Hemmo PharmaceuticalsIn March this year, Piramal Pharma Ltd entered into an agreement to acquire a 100 per cent stake in Hemmo Pharmaceuticals for an upfront co...
- Morepen gets shareholder nod to raise Rs 433 croreMorepen said it plans to utilise the raised capital to expand research and development (R&D) facilities and to set up a new USFDA standard ...
- Piramal Pharma to acquire 100% stake in Hemmo Pharma for Rs 775 crConsequent to the acquisition, Hemmo Pharmaceuticals Pvt Ltd would become a wholly-owned subsidiary of Piramal Pharma Ltd (PPL).
- PE fund Advent International to buy ZCL ChemicalsAdvent will buy about 51% stake in ZCL at an enterprise value of Rs1700 crore, said sources in the know. With this transaction, existing in...
- Bajaj Healthcare to buy stressed assets from Saraswat Cooperative Bank for Rs 61 croreThe company has agreed to acquire stressed assets from Saraswat Cooperative Bank by way of cash consideration of Rs 61 crore subject to clo...
- TPG to acquire 40% in Sai Life for Rs 900 croreTPG will seal the deal through secondary share purchase from existing investor Tata Capital, followed by a primary infusion into the two-de...
- Citi,Warburg eye 15% in Ansal API Dadri projectCitigroup and Warburg Pincus are in talks with Sushil Ansal-promoted Ansal API to pick up a 15% stake in its Rs 13,000-crore Dadri Megapoli...
- Lupin Q4 profit soars to Rs 137 crDrugmaker Lupin on Wednesday reported close to three-fold growth in net profit to Rs 137.08 crore for the three months ended March 31, 2007...
- Sun Pharma scouts for supply tie-ups in EuropeMumbai-based Sun Pharma is about to give its bulk drug business a shot in the arm - it’s scouting for tie-ups in Europe to supply a range o...
- Indoco buys La NovaChem unitIndoco Remedies, a Rs 215-crore Mumbai-based pharmaceutical company, has acquired La NovaChem’s active pharmaceutical ingredient (API) manu...
Load More
